s100b
6
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
A Study of the Determinants of Neurological Outcomes in Patients With Acute Respiratory Distress Syndrome
Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
The Neuroprotective Effects of RPC on the Neurosurgery